Meta Pixel

News and Announcements

New Appointments Strengthen the Technical Team of First Graphene (ASX: FGR)

  • Published August 20, 2018 12:00AM UTC
  • Publisher Wholesale Investor
  • Categories Company Updates

KEY TAKEAWAYS:

  • Appointment of Chemical & Process Engineer at Henderson
  • Appointment of Chartered Chemical Engineer at Manchester

Advanced materials company, First Graphene Limited (ASX: FGR) is pleased to advise the commencement of Neil Armstrong as Chemist & Process Engineer at the Henderson Graphene Facility and the appointment of Paul Ladislaus to head up the Manchester-based Graphene Engineering Innovation Centre as Senior Process Engineer. These two appointments will further strengthen the Company’s technical capabilities as it is building its team for the commercialisation of its graphene products.

Neil Armstrong

Neil comes to FGR with a strong background in design and manufacture of high performing composite materials and production processes used in a variety of applications, and in particular the mining industry. He has a Bachelor of Engineering (Honours) in (Chemical/Process Engineering) and is progressing on a Masters of Renewable and
Sustainable Energy.

His background in continuous technical support and a hands-on approach throughout all stages of development, in addition to providing onsite consultations and component evaluations we be valuable to FGR as we deliver bespoke products to customers.

Paul Ladislaus

Paul is a Chartered Chemical Engineer with a successful track record of working in Operational, Project Management, R&D and Process Technology Roles. His previous roles have included leadership of the development and scale-up of new technologies for the production of next-generation materials, such as carbon nanotubes and graphene. He was previously Process Technology Team Leader – Advanced Materials Division at Thomas Swan & Co Ltd. Paul will commence with First Graphene (UK) Limited in November and be based in Manchester at the Graphene Engineering Innovation Centre, where he will head up FGR’s commercialisation projects. Managing Director, Craig McGuckin, stated: “FGR is pleased to have Neil and Paul joining the team. Their skills and background will be vital as we develop bespoke advanced materials solutions for our
customers.”

About First Graphene Ltd (ASX: FGR)

First Graphene has established a commercial graphene production facility for the bulk scale manufacture of graphene at competitive prices. The Company continues to develop graphene-related intellectual property from which it intends to generate licence and royalty payments.

The Company has collaboration arrangements with four universities and is at the cutting edge of graphene and 2D related material developments. Most recently First Graphene has become a Tier 1 participant in the Graphene Engineering and Innovation Centre (GEIC) of the University of Manchester. First Graphene is working with numerous industry partners for the commercialisation of graphene and is building a sales book with these industry partners.

Register Interest

Capital Insights
The Light Fantastic: Why Invion’s Photodynamic Therapy May Be  Attracting Big Pharma’s Attention

Invion Limited is challenging the status quo in oncology with its Photosoft™ platform, a precision therapy that uses light-activated molecules to selectively target cancer cells. By transforming the body’s own immune response and addressing the high costs of current cancer treatments, Invion is positioning itself as a transformative player in the biotech sector. With clinical trials underway and strong institutional partnerships, the company is bridging the gap between scientific breakthrough and accessible, scalable patient care.

Capital Insights
From Outback to Boardroom: How SWAN Systems is Codifying Water Stewardship

From the arid deserts of Australia to the boardrooms of global tech giants, SWAN Systems is redefining water efficiency. By bridging the gap between field-level agronomics and autonomous irrigation control, the company is proving that “water-positive” targets can be met with science, data, and a 10x ROI commitment.

Join over 45,000+ sophisticated investors

Join Now